ABSTRACT
BACKGROUND: Atrial myxomas are very infrequent primary bening cardiac neoplasms, being considered a rare but highly fatal cause of cerebral embolism. Objectives: We describe the case of an ischemic stroke (CVA) with hemorrhagic conversion secondary to atrila myxoma as an embolic source, and its subsequent early surgical resolution. CLINICAL CASE: A 63-year-old male has a clinical episode compatible with ischemic stroke, receiving thrombolytics treatment with subsequent hemorrhagic conversion. Embolic source study show a mass compatible with cardiac myxoma in the left atrium, performing surgical resection via transeptal approach at 12 days of evolution, with repair of the interatrial defect with autologous pericardium patch. DISCUSSION: Atrial myxoma is a silent pathology and little diagnosed at its early stage, associated with events of systemic repercussion of high mortality and uncertain prognosis. Hemorrhagic cerebrovascular events constitute contraindication for anticoagulation prior to 21 days of evolution. In this case, due to the high embolic risk of myxoma, the inactivy of the bleeding was demonstrated by performing the surgery successfully on the twelfth day of evolution.
Subject(s)
Humans , Male , Middle Aged , Stroke/etiology , Heart Neoplasms/complications , Myxoma/complications , Echocardiography, Doppler , Intracranial Embolism/etiology , Tomography, Spiral Computed/methods , Heart AtriaABSTRACT
Introducción: La isquemia critica de las extremidades inferiores (EEII) es una condición que afecta a pacientes que presentan grave patología ateromatosa en múltiples territorios y por ende tienen mal pronostico vital. La terapia endovascular validada en algunos sectores, en éste no ha logrado posicionarse. Objetivo: Evaluar la evolución de los pacientes sometidos a Angioplastia Endoluminal Percutánea (AGP) del territorio femoropoplíteo por isquemia critica. Material y Método: Estudio retrospectivo que incluye 58 extremidades en 54 pacientes con isquemia critica de las EE.II por patología femoropoplítea, sometidos a angioplastia entre Julio del 2001 a Diciembre del 2004 y seguidos en su evolución hasta Abril del 2006. Resultados: Fueron realizadas 58 AGP (54 pacientes): masculinos 54 por ciento, femeninos 46 por ciento, y 74 por ciento diabéticos. Edad promedio 70,6 años. El grupo incluye lesiones TASC A, B, C y D. El 24 por ciento de las extremidades no tenía run off. Éxito técnico inicial se obtuvo en el 84 por ciento. La permeabilidad primaria 43,3 por ciento a 1 año (ES 6,52), 32,7 por ciento a 2 años (ES 7,44) y 16,9 por ciento a 3 años (ES 6,31). Durante el periodo, 4 pacientes fueron sometidos a nuevas angioplastias del mismo territorio y 7 pacientes a by pass. Mortalidad a 30 días 1,7 por ciento. Existieron 4 complicaciones mayores (8 por ciento). Al término del seguimiento hay 20 amputaciones mayores (34 por ciento), cuatro de ellas por compromiso local, las restantes por isquemia irreversible. La mortalidad al final del seguimiento fue de 29,6 por ciento. Conclusión: La angioplastia infrainguinal en la isquemia crítica es posible, segura y de baja morbimortalidad, no excluyendo revascularizar mediante by pass si fracasa.
Introduction: The critical ischemia of the lower extremities is a condition that affects patients who present serious atheromatous pathology in multiple territories and, consequently, have bad live prognosis. Endovascular therapy, valid in some sectors, has not been able to find a position in this one yet. Objectives: to evaluate the gradual development of patients who were subjected to angioplasty of the femoropopliteal territory because of critical ischemia. Material and method: retrospective study, which includes 58 extremities in 54 patients with critical ischemia of the interior extremities due to femoropopliteal pathology who were subjected to angioplasty between July 2001 and December 2004, and whose development was studied until April 2006. Results: 58 AGP were performed in 54 patients: 54 percent male, 46 percent female, and 74 percent diabetics. The average age was 70.6 years old. The group includes TASC A, B, C, and D lesions. 24 percent of the extremities did not have run off. The initial technical success was obtained in 84 percent of the cases. The primary permeability 43,3 percent after a year (ES 6,52), 32,7 percent after 2 years (ES 7,44) and 16,9 percent after 3 years (ES 6,31). 4 patients were subjected to further angioplasty of the same territory and 7 patients were subjected to bypass during this period. The 30-day mortality was 1,7 percent. There were 4 major complications (8 percent). By the end of the monitoring, there are 20 major amputations (34 percent), 4 of these due to local compromise, and the rest of them due to irreversible ischemia. The mortality at the end of the monitoring was 29,6 percent. Conclusion: infrainguinal angioplasty on critical ischemia is possible, safe and presents a low morbimortality, not excluding revascu-larization through bypass in case of failure.